Trump Unveils Phased Generic Drug Tariff Plan President Donald Trump has announced a phased tariff plan targeting imported generic pharmaceutical products, with rates escalating from 0% initially to 100% by…
The Central Drugs Standard Control Organisation (CDSCO) has approved two new treatment options for metabolic dysfunction-associated steatohepatitis (MASH), commonly known as fatty liver disease, marking a significant advancement in India's…
On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves…
The ongoing Iran war and the disruption of shipping through the Strait of Hormuz have triggered one of the most significant shocks to global pharmaceutical supply chains in decades. For…